Practice Area

Patent Litigation

Publications

April 27, 2016 A Breakthrough Technology is Caught in an Epic Patent Battle

March 16, 2016 Biosimilar Makers Turn To IPRs Despite Mixed Results

December 9, 2015 All Camps Agree: Memorable Biosimilar Names are a Must

October 27, 2015 TPP Biologics Exclusivity Period Maintains The Status Quo

June 2015 Biobetters: The Advantages and Challenges of Being Better

June 2015 New Targets in the Crosshairs: A forum to invalidate patents is now being used on biotech firms

April 2015 The Value of Being Highly Similar: First U.S. Biosimilar

October 2014 If High Court Reverses Teva, Litigation Costs May Increase

May 2014 An Unforeseen Obstacle: Consultants Can Prevent Validity Challenges Through the Use of the Assignor Estoppel Doctrine

February 2012 FDA Issues Draft Guidelines for Biosimilars

January 2012 Partnering With The Feds For IP Enforcement: Part 1

June 2011 Supreme Court Decision: Board of Trustees of the Leland Stanford Junior University v. Roche Molecular Systems, Inc.

May 2011 IP Audits: Making the Most of Your Intellectual Property

April 9, 2010 Federal Circuit Reinvigorates the Written Description Requirement

June 2009 On Appeal Alert: Federal Circuit Grants Mandamus on Motion to Transfer Venue

Spring 2008 IP OnTrial